Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for Microvascular Function in Metabolic Syndrome
NCT01887119Phase 4Terminated
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2013
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in metabolic syndrome, insulin resistance (IR), hypertension (HTN), sponsored by Maastricht University Medical Center+. Started Oct 2013; status: terminated.
02
Drugs
eplerenone
03
Conditions
metabolic syndromeinsulin resistance (IR)hypertension (HTN)
Beyond the preview
Go deeper on NCT01887119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01887119.